Andrew Jennings serves as the Senior Director of Commercial Finance at NewAmsterdam Pharma Corporation, where he leverages his extensive background in finance and accounting to drive strategic initiatives within the life sciences sector. With a robust understanding of financial management, Andrew oversees all aspects of...
Andrew Jennings serves as the Senior Director of Commercial Finance at NewAmsterdam Pharma Corporation, where he leverages his extensive background in finance and accounting to drive strategic initiatives within the life sciences sector. With a robust understanding of financial management, Andrew oversees all aspects of the company's financial operations, ensuring compliance with US GAAP and regulatory requirements while maintaining the highest standards of internal controls and SOX compliance. His expertise in financial reporting and analysis plays a crucial role in preparing insightful reports for senior management, board meetings, and external stakeholders, enabling informed decision-making that aligns with the company’s objectives.
At NewAmsterdam Pharma, Andrew is instrumental in leading key projects that focus on the development and execution of financial strategies aimed at optimizing resource allocation and enhancing profitability. His proficiency in ERP systems, particularly SAP, allows him to streamline financial processes and improve reporting accuracy, thereby facilitating effective financial planning and forecasting. Andrew’s ability to collaborate with diverse groups, including senior management and executive leaders, underscores his commitment to fostering a culture of transparency and strategic alignment across the organization.
With a keen eye for detail and a strategic mindset, Andrew Jennings is dedicated to driving financial excellence at NewAmsterdam Pharma, positioning the company for sustainable growth in the competitive life sciences landscape. His blend of technical accounting skills and strategic financial planning expertise makes him a pivotal figure in navigating the complexities of the industry while ensuring that the company remains compliant and financially sound.
